Sector Update: Healthcare Stocks Gain Friday Afternoon

MT newswire2026/10/09 17:50

01:50 PM EDT, 10/09/2026 (MT Newswires) -- Healthcare stocks rose Friday afternoon, with the NYSE Healthcare Index up 1.2% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.6%. The iShares Biotechnology ETF (IBB) climbed 3%. In corporate news, Humana (HUM) shares surged nearly 12% after it affirmed its full-year 2026 guidance of at least $9 in adjusted earnings per common share. Humana also said Friday that 95% of its Medicare Advantage members are enrolled in plans with ratings of at least four stars by the Centers for Medicare and Medicaid Services for 2027, which it called a "significant improvement." Shares of Moderna (MRNA) and other vaccine developers rose after The New York Times reported that the US National Institutes of Health is part of a public-private partnership to accelerate the development of cancer vaccines. Moderna shares jumped 12%. Merck (MRK), Novavax (NVAX) and BioNTech (BNTX) shares were up 3%, 15% and 5.2%, respectively. Vaxcyte (PCVX) and Vir Biotechnology (VIR) shares popped nearly 9% and 6%, respectively. TRex Bio (TRXB) shares were down 2.5% after the company's Nasdaq debut. The biotech company priced its initial public offering of around 8.3 million common shares at $14 apiece for gross proceeds of $116.7 million.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

After earning nearly $1 million in profit last year, a major WLD whale has reached a trading volume of $22 million this year and has given back all of its profits.

Odaily星球日报•2026/10/25 11:49

Worst-Performing Altcoins This Week as BTC Battles to Hold $80K: Weekend Watch

Cryptopotato•2026/10/25 11:45

Goldman Sachs dramatically lowers KOSPI target from 12,000 to 9,000 points, still insists there is 60% upside potential

Goldman Sachs strategists have lowered their 12-month target for South Korea's KOSPI Index from 12,000 points to 9,000 points, representing a 25% decrease. Earlier this year, Goldman had raised the target multiple times. The latest downgrade is due to mounting concerns in the market over artificial intelligence (AI) trading.

智通财经•2026/10/25 10:51

AI investment has not ended; wealth is simply being redistributed.

404k•2026/10/25 09:19